Yu Yao Selected Research

human pituitary tumor-transforming protein 1

9/2004

[Human pituitary tumor transforming gene 1 expression in ovarian carcinoma and its clinical significance].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu Yao Research Topics

Disease

74	Neoplasms (Cancer) 01/2022 - 07/2002
31	Glioma (Gliomas) 01/2021 - 06/2009
17	Glioblastoma (Glioblastoma Multiforme) 11/2019 - 12/2010
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2022 - 02/2003
11	Breast Neoplasms (Breast Cancer) 04/2022 - 03/2015
11	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2013
10	Inflammation (Inflammations) 01/2022 - 01/2010
9	Adenocarcinoma of Lung 01/2022 - 12/2008
7	Carcinogenesis 01/2022 - 06/2014
7	Hypoxia (Hypoxemia) 01/2021 - 05/2015
7	Carcinoma (Carcinomatosis) 01/2021 - 07/2002
6	Lung Neoplasms (Lung Cancer) 02/2022 - 01/2015
6	Brain Neoplasms (Brain Tumor) 01/2022 - 07/2014
5	Intervertebral Disc Displacement (Herniated Disc) 06/2022 - 10/2015
5	Pain (Aches) 06/2022 - 12/2014
5	Sickle Cell Anemia (Hemoglobin S Disease) 01/2021 - 01/2016
5	Hepatocellular Carcinoma (Hepatoma) 08/2018 - 04/2009
4	Medulloblastoma 01/2017 - 11/2012
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 03/2017
3	Infarction (Infarctions) 04/2018 - 08/2005
3	Colorectal Neoplasms (Colorectal Cancer) 11/2014 - 01/2013
3	Lymphatic Metastasis 02/2014 - 01/2013
3	Ovarian Neoplasms (Ovarian Cancer) 12/2006 - 09/2004
2	Ischemic Stroke 01/2022 - 04/2018
2	Obesity 01/2022 - 05/2015
2	Hypoproteinemia 01/2022 - 01/2020
2	Colonic Neoplasms (Colon Cancer) 01/2022 - 01/2013
2	Melanoma (Melanoma, Malignant) 01/2022 - 02/2021
2	Hemorrhage 01/2022 - 09/2016
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 01/2020
2	Septic Shock (Toxic Shock Syndrome) 01/2022 - 01/2020
2	Postoperative Pain 01/2022 - 01/2020
2	Insulin Resistance 01/2022 - 05/2015
2	Macular Degeneration (Age-Related Maculopathy) 10/2021 - 01/2020
2	Chronic Hepatitis B 01/2021 - 01/2014
2	Epilepsy (Aura) 01/2021 - 12/2003
2	Adenocarcinoma 01/2021 - 01/2021
2	Hypertension (High Blood Pressure) 01/2020 - 08/2012
2	Esophageal Squamous Cell Carcinoma 01/2020 - 02/2018
2	Thalassemia 11/2019 - 01/2016
2	Graves Disease (Basedow Disease) 01/2019 - 04/2013

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2004
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2014
9	Pharmaceutical PreparationsIBA 01/2022 - 11/2010
9	AntigensIBA 01/2021 - 09/2005
8	Immune Checkpoint InhibitorsIBA 03/2022 - 01/2020
7	Messenger RNA (mRNA)IBA 02/2022 - 09/2004
6	MicroRNAs (MicroRNA)IBA 01/2021 - 11/2009
6	Small Interfering RNA (siRNA)IBA 07/2017 - 09/2013
6	Biological ProductsIBA 05/2016 - 07/2002
5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2019
5	GlobinsIBA 01/2021 - 01/2016
5	Monoclonal AntibodiesIBA 05/2015 - 09/2005
4	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2019
4	Peptides (Polypeptides)IBA 01/2022 - 01/2014
4	Long Noncoding RNAIBA 09/2021 - 01/2017
4	Circulating Tumor DNAIBA 02/2021 - 01/2017
4	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2018 - 03/2015
4	ChemokinesIBA 04/2018 - 01/2010
3	Bevacizumab (Avastin)FDA Link 03/2022 - 08/2012
3	HydrogelsIBA 05/2021 - 03/2016
3	Fetal Hemoglobin (Hemoglobin F)IBA 01/2021 - 11/2019
3	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2013
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2016
3	GoldIBA 01/2019 - 10/2017
3	Hyaluronic Acid (Hyaluronan)IBA 01/2019 - 03/2016
3	LigandsIBA 01/2018 - 12/2012
3	Folic Acid (Vitamin M)FDA LinkGeneric 07/2017 - 03/2015
3	Lysine (L-Lysine)FDA Link 07/2016 - 03/2016
3	Temozolomide (Temodar)FDA LinkGeneric 06/2016 - 12/2010
3	EnzymesIBA 07/2014 - 09/2005
3	FlagellinIBA 12/2012 - 01/2010
2	Oxygen (Dioxygen)IBA 01/2022 - 05/2015
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022 - 12/2021
2	Serum AlbuminIBA 01/2022 - 01/2020
2	Interleukin-22 (IL-22)IBA 01/2022 - 01/2020
2	Retinal Pigments (Pigments, Visual)IBA 10/2021 - 01/2020
2	NucleotidesIBA 01/2021 - 01/2021
2	Hemoglobins (Hemoglobin)IBA 01/2021 - 01/2016
2	PlatinumIBA 01/2021 - 01/2020
2	ElementsIBA 01/2021 - 10/2018
2	AntibodiesIBA 01/2021 - 01/2015
2	CytokinesIBA 12/2020 - 04/2010
2	Competitive Endogenous RNAIBA 01/2020 - 01/2020
2	Interferon-gamma (Interferon, gamma)IBA 11/2019 - 01/2011
2	Interleukin-2 (IL2)IBA 11/2019 - 12/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2019 - 08/2003
2	Glutathione (Reduced Glutathione)IBA 01/2019 - 03/2015
2	CateninsIBA 01/2019 - 11/2014

Therapy/Procedure

32	Therapeutics 01/2022 - 12/2003
17	Drug Therapy (Chemotherapy) 03/2022 - 02/2003
10	Immunotherapy 01/2021 - 12/2006
6	Radiotherapy 07/2021 - 08/2012
4	Diskectomy (Discectomy) 06/2022 - 01/2016
4	Transplantation 01/2022 - 12/2008
3	Photothermal Therapy 01/2019 - 10/2017
3	Precision Medicine 01/2019 - 01/2017
2	Mastectomy (Mammectomy) 04/2022 - 11/2019
2	Operative Time 01/2022 - 12/2014
2	Adjuvant Chemotherapy 01/2021 - 01/2014